PROS1 and COVID-19: This has been demonstrated for another MVA-based COVID-19 vaccine expressing a non-stabilized S-protein (MVA-S) [36], which showed strong neutralizing antibody responses when administered as an LD intranasal boost vaccination following intramuscular priming [36, 37].